Chroma Medicine is a cutting-edge biotechnology company at the forefront of genomic medicine. They are pioneering a novel class of therapeutics using epigenetic editing, which leverages the body's natural mechanisms to control gene expression. Unlike traditional gene editing approaches that cut DNA, Chroma's platform aims to durably silence, activate, or multiplex genes in vivo by precisely writing epigenetic marks. This innovative approach has the potential to create single-dose treatments for a wide range of serious diseases with greater precision and control. The company is focused on advancing its discovery programs and translating its science into transformative medicines for patients.
Serves as the central hub for research and development, corporate operations, strategic planning, and translational science for its epigenetic editing programs.
State-of-the-art laboratory facilities designed to support advanced genomic research and therapeutic development. Located within a prominent biotech hub in Cambridge.
A dynamic, innovative, and collaborative environment focused on pioneering scientific breakthroughs. Emphasizes teamwork, scientific rigor, and a patient-centric mission.
Crucial for advancing Chroma Medicine's proprietary epigenetic editing platform, fostering innovation, and progressing its pipeline of genomic medicines.
While headquartered in Cambridge, MA, Chroma Medicine's global presence is primarily characterized by its scientific collaborations with international researchers and institutions, engagement with the global scientific community through publications and conferences, and strategic planning for future clinical development and market access for its novel epigenetic therapies. The company actively builds intellectual property globally for its platform and therapeutic candidates.
200 CambridgePark Drive, Suite 3000
Cambridge
MA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Chroma Medicine' leadership includes:
Chroma Medicine has been backed by several prominent investors over the years, including:
Chroma Medicine has strengthened its leadership with key appointments at the Vice President level in the past 12 months, while the core C-suite has maintained stability. No major C-level exits have been reported.
Discover the tools Chroma Medicine uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Chroma Medicine likely utilizes common corporate email formats. The most probable format combines the first initial and last name of the employee.
[first_initial][last]@chromamedicine.com
Format
jdoe@chromamedicine.com
Example
90%
Success rate
Chroma Medicine Press Release • January 3, 2024
Chroma Medicine presented promising preclinical data at the ASH Annual Meeting, showcasing the potential of its epigenetic editing technology for in vivo gene silencing with applications in treating serious diseases....more
Chroma Medicine Press Release • November 20, 2023
Research by Chroma Medicine scientists and collaborators, published in Nature Biotechnology, detailed the foundational demonstration of their epigenetic editor technology for achieving targeted and durable gene silencing....more
Chroma Medicine Press Release • February 15, 2023
Chroma Medicine secured $135 million in Series B financing led by GV (Google Ventures), with participation from other new and existing investors, to advance its pioneering epigenetic editing platform and therapeutic pipeline....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Chroma Medicine, are just a search away.